Danielle L Chandler: Influence Statistics

Danielle L Chandler

Danielle L Chandler

Jaeb Center for Health Research, Tampa, Florida | Jaeb Center for Health Research, Tampa, Florida. | Jaeb Center for Health Research, Tampa, Florida, USA | Jaeb Center for ...

Danielle L Chandler: Expert Impact

Concepts for which Danielle L Chandler has direct influence: Nasolacrimal duct obstruction , Intermittent exotropia , Primary treatment , Ocular alignment , Nasolacrimal duct , Visual acuity , Age 10 years .

Danielle L Chandler: KOL impact

Concepts related to the work of other authors for which for which Danielle L Chandler has influence: Visual acuity , Multiple sclerosis , Intermittent exotropia , Amblyopia treatment , Nasolacrimal duct , Macular edema , Occlusion therapy .

KOL Resume for Danielle L Chandler

Year
2021

Jaeb Center for Health Research, Tampa, Florida

2019

Jaeb Center for Health Research, Tampa, Florida, USA

2010

Jaeb Center for Health Research, Tampa, Florida (Mss Melia and Chandler)

2003

Jaeb Center for Health Research, Tampa, Florida, USA (D.L.C., R.W.B., P.S.M.)

2002

CHAMPS Analysis Center, Jaeb Center for Health Research, Tampa, FL

Prominent publications by Danielle L Chandler

KOL-Index: 13463 . OBJECTIVE: To determine the effectiveness of prescribed part-time patching for treatment of intermittent exotropia (IXT) in children. DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: Three hundred fifty-eight children 3 to <11 years of age with previously untreated (except for refractive correction) IXT and near stereoacuity of 400 seconds of arc or better were enrolled. ...
Known for Intermittent Exotropia | Distance Ixt | 10 Years | Observation Treatment
KOL-Index: 12740 . PURPOSE: To report the outcome of nasolacrimal duct intubation as the primary treatment of congenital nasolacrimal duct obstruction (NLDO) in children younger than 4 years of age. METHODS: A total of 182 eyes of 139 children receiving intubation with planned tube retention for 2 to 5 months were enrolled in a prospective, nonrandomized observational multicenter study (19 sites). Children ...
Known for Primary Treatment | Nasolacrimal Duct | Nldo Children | Mucous Discharge
KOL-Index: 12491 . PURPOSE: To develop a computerized method of visual acuity testing for clinical research as an alternative to the standard Early Treatment for Diabetic Retinopathy Study (ETDRS) testing protocol, and to evaluate its test-retest reliability and concordance with standard ETDRS testing. DESIGN: Test-retest reliability study. METHODS: Multicenter setting of a study population of 265 patients ...
Known for Visual Acuity | Computerized Method | Diabetic Retinopathy | Testing Protocol
KOL-Index: 12168 . OBJECTIVE: To determine the visual acuity outcome at age 10 years for children younger than 7 years when enrolled in a treatment trial for moderate amblyopia. METHODS: In a multicenter clinical trial, 419 children with amblyopia (visual acuity, 20/40-20/100) were randomized to patching or atropine eyedrops for 6 months. Two years after enrollment, a subgroup of 188 children entered ...
Known for 10 Years | Visual Acuity | Atropine Patching | Moderate Amblyopia
KOL-Index: 12149 . OBJECTIVE: To report the outcome of nasolacrimal duct probing as the primary treatment of congenital nasolacrimal duct obstruction (NLDO) in children younger than 4 years. DESIGN: Prospective nonrandomized observational multicenter study (44 sites). PARTICIPANTS: Nine hundred fifty-five eyes of 718 children 6 to <48 months old at the time of surgery with no prior nasolacrimal surgical ...
Known for Primary Treatment | Nasolacrimal Duct | Nldo Children | 48 Months
KOL-Index: 9869 . OBJECTIVE: To compare 2 hours vs 6 hours of daily patching as treatments for moderate amblyopia in children younger than 7 years. METHODS: In a randomized multicenter (35 sites) clinical trial, 189 children younger than 7 years with amblyopia in the range of 20/40 to 20/80 were assigned to receive either 2 hours or 6 hours of daily patching combined with at least 1 hour per day of near ...
Known for Moderate Amblyopia | Daily Patching | Amblyopic Eye | 2 Hours
KOL-Index: 9513 . PURPOSE: To report the outcome of nasolacrimal duct balloon catheter dilation as the primary treatment of congenital nasolacrimal duct obstruction (NLDO) in children younger than 4 years of age. METHODS: One hundred two children (151 eyes) ages 12 to <48 months (mean, 23 months) at the time of surgery, who previously had not undergone a nasolacrimal surgical procedure and who presented ...
Known for Primary Treatment | Nasolacrimal Duct | Balloon Catheter | 48 Months
KOL-Index: 9250 . PURPOSE: To develop and validate a new parental questionnaire addressing symptoms and health-related quality of life (HRQL) in childhood nasolacrimal duct obstruction (NLDO). DESIGN: Cross-sectional study. PARTICIPANTS: Children ages 6 to younger than 48 months with and without clinical signs of NLDO. METHODS: A new questionnaire was developed using semistructured interviews with parents ...
Known for Nasolacrimal Duct | Life Questionnaire | Symptom Survey | Parents Children
KOL-Index: 8874 . PURPOSE: To determine the amount and time course of binocular visual acuity improvement during treatment of bilateral refractive amblyopia in children three to less than 10 years of age. DESIGN: Prospective, multicenter, noncomparative intervention. METHODS: One hundred and thirteen children (mean age, 5.1 years) with previously untreated bilateral refractive amblyopia were enrolled at 27 ...
Known for Bilateral Refractive Amblyopia | Binocular Visual Acuity | 10 Years | Children Age
KOL-Index: 8572 . PURPOSE: To assess the test-retest reliability of the electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) visual acuity algorithm using the computerized Electronic Visual Acuity (EVA) tester in children 7 to <13 years old. DESIGN: Test-retest reliability study. METHODS: This multicenter study involved 245 subjects at four clinical sites. As the main outcome measure, visual ...
Known for Diabetic Retinopathy | Visual Acuity | Testretest Reliability | Outcome Measure
KOL-Index: 8535 . The objective of this work was to assess the effect of interferon beta-1a (Avonex) on the rate of development of clinically definite multiple sclerosis and brain magnetic resonance imaging changes in subgroups based on type of presenting event, baseline brain magnetic resonance imaging parameters, and demographic factors in the Controlled High-Risk Subjects Avonex Multiple Sclerosis ...
Known for Multiple Sclerosis | Magnetic Resonance | Optic Neuritis | Clinically Definite
KOL-Index: 8226 . OBJECTIVE: To compare the outcomes of balloon catheter dilation and nasolacrimal intubation as treatment for congenital nasolacrimal duct obstruction after failed probing in children younger than 4 years. METHODS: We conducted a prospective, nonrandomized, multicenter study that enrolled 159 children aged 6 months to younger than 48 months who had a history of a single failed nasolacrimal ...
Known for Nasolacrimal Duct | Balloon Catheter Dilation | Treatment Success | Clinical Signs
KOL-Index: 7962 . PURPOSE: To compare long-term outcomes after bilateral lateral rectus recession (BLRc) or unilateral lateral rectus recession combined with medial rectus resection in the same eye (R&R) for primary treatment of childhood intermittent exotropia (IXT). DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: One hundred ninety-seven children 3 to younger than 11 years of age with ...
Known for 3 Years | Lateral Rectus | Intermittent Exotropia | Surgical Outcome
KOL-Index: 7722 . PURPOSE: To determine whether demographic or clinical factors are associated with the outcome of office-based nasolacrimal duct probing for the treatment of congenital nasolacrimal duct obstruction (NLDO). METHODS: In two multicenter prospective studies, 384 eyes of 304 children aged 6 to <15 months with NLDO underwent a nasolacrimal duct probing performed in the office using topical ...
Known for Nasolacrimal Duct | Office Probing | Treatment Success | Topical Anesthesia
KOL-Index: 7485 . OBJECTIVE: To assess the stability of visual acuity improvement during the first year after cessation of amblyopia treatment other than spectacle wear in children aged 7 to 12 years. METHODS: At the completion of a multicenter randomized trial during which amblyopia treated with patching and atropine improved by at least 2 lines on the electronic Early Treatment of Diabetic Retinopathy ...
Known for Visual Acuity | Amblyopia Treatment | Children Aged | 12 Years

Key People For Nasolacrimal Duct Obstruction

Top KOLs in the world
#1
John V Linberg
congenital ptosis orbital septum floppy eyelid syndrome
#2
John J Woog
graves ophthalmopathy orbital radiation endonasal dacryocystorhinostomy
#3
Dale Robert Meyer
nasolacrimal duct orbital radiation intravenous sedation
#4
Geoffrey E Rose
lacrimal gland thyroid eye disease orbital decompression
#5
Peter‐John Wormald
chronic rhinosinusitis staphylococcus aureus endoscopic sinus surgery
#6
Steven A McCormick
uveal melanocytes melanoma cells ultrasound biomicroscopy

Jaeb Center for Health Research, Tampa, Florida | Jaeb Center for Health Research, Tampa, Florida. | Jaeb Center for Health Research, Tampa, Florida, USA | Jaeb Center for Health Research, Tampa, Florida (Mss Melia and Chandler) | Jaeb Center for Hea